FR2320760A1 - Utilisation therapeutique nouvelle des gangliosides et procede pour leur extraction - Google Patents
Utilisation therapeutique nouvelle des gangliosides et procede pour leur extractionInfo
- Publication number
- FR2320760A1 FR2320760A1 FR7540170A FR7540170A FR2320760A1 FR 2320760 A1 FR2320760 A1 FR 2320760A1 FR 7540170 A FR7540170 A FR 7540170A FR 7540170 A FR7540170 A FR 7540170A FR 2320760 A1 FR2320760 A1 FR 2320760A1
- Authority
- FR
- France
- Prior art keywords
- paralysis
- nervous
- tetra
- tri
- conduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000035475 disorder Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 210000003169 central nervous system Anatomy 0.000 title 1
- 210000001428 peripheral nervous system Anatomy 0.000 title 1
- 206010033799 Paralysis Diseases 0.000 abstract 3
- 230000002490 cerebral effect Effects 0.000 abstract 2
- 230000003902 lesion Effects 0.000 abstract 2
- 210000000578 peripheral nerve Anatomy 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- 206010001014 Acute polyneuropathies Diseases 0.000 abstract 1
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 206010006542 Bulbar palsy Diseases 0.000 abstract 1
- 208000005189 Embolism Diseases 0.000 abstract 1
- 208000035895 Guillain-Barré syndrome Diseases 0.000 abstract 1
- 206010049567 Miller Fisher syndrome Diseases 0.000 abstract 1
- 206010028372 Muscular weakness Diseases 0.000 abstract 1
- 206010029240 Neuritis Diseases 0.000 abstract 1
- 208000009032 Obstetric Paralysis Diseases 0.000 abstract 1
- 208000003435 Optic Neuritis Diseases 0.000 abstract 1
- 206010036105 Polyneuropathy Diseases 0.000 abstract 1
- 206010037779 Radiculopathy Diseases 0.000 abstract 1
- 208000008765 Sciatica Diseases 0.000 abstract 1
- 208000034189 Sclerosis Diseases 0.000 abstract 1
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 201000011101 acute retrobulbar neuritis Diseases 0.000 abstract 1
- 230000001476 alcoholic effect Effects 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001815 facial effect Effects 0.000 abstract 1
- 150000002270 gangliosides Chemical class 0.000 abstract 1
- 210000002161 motor neuron Anatomy 0.000 abstract 1
- 230000003387 muscular Effects 0.000 abstract 1
- 201000006938 muscular dystrophy Diseases 0.000 abstract 1
- 230000036473 myasthenia Effects 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 210000002589 oculomotor nerve Anatomy 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 208000019629 polyneuritis Diseases 0.000 abstract 1
- 201000002241 progressive bulbar palsy Diseases 0.000 abstract 1
- 230000000750 progressive effect Effects 0.000 abstract 1
- 206010061928 radiculitis Diseases 0.000 abstract 1
- 208000022670 retrobulbar neuritis Diseases 0.000 abstract 1
- 230000005062 synaptic transmission Effects 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 230000000472 traumatic effect Effects 0.000 abstract 1
- 208000019553 vascular disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Extraction Or Liquid Replacement (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT26323/75A IT1046051B (it) | 1975-08-13 | 1975-08-13 | Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2320760A1 true FR2320760A1 (fr) | 1977-03-11 |
| FR2320760B1 FR2320760B1 (enExample) | 1978-11-17 |
Family
ID=11219226
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7540170A Granted FR2320760A1 (fr) | 1975-08-13 | 1975-12-30 | Utilisation therapeutique nouvelle des gangliosides et procede pour leur extraction |
Country Status (7)
| Country | Link |
|---|---|
| JP (2) | JPS5234912A (enExample) |
| AT (1) | AT352296B (enExample) |
| BE (1) | BE843695A (enExample) |
| DE (1) | DE2549680A1 (enExample) |
| ES (1) | ES441233A1 (enExample) |
| FR (1) | FR2320760A1 (enExample) |
| IT (1) | IT1046051B (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980001875A1 (fr) * | 1979-03-16 | 1980-09-18 | Merieux Inst | Nouveau medicament, notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
| FR2451194A1 (fr) * | 1979-03-16 | 1980-10-10 | Merieux Inst | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
| WO1981003175A1 (en) * | 1980-05-09 | 1981-11-12 | H Leffler | Carbohydrate derivatives for inhibiting bacterial adherence |
| EP0038511A3 (en) * | 1980-04-17 | 1982-08-18 | Rolf Dr. Schaefer | Wound healing compositions |
| EP0126817A1 (en) * | 1983-05-27 | 1984-12-05 | Shanksville Corporation N.V. | Suppressing of graft rejection in organ transplantation |
| EP0332191A3 (en) * | 1988-03-10 | 1990-05-16 | Mect Corporation | Sialosyl glyceride and process for producing the same |
| EP0409473A3 (en) * | 1989-07-12 | 1992-04-29 | Carlos Mammarella | A process for obtaining the gangliosides from nervous tissue of mammalians and for the treatment of psychoorganic diseases with said material compositons |
| RU2192871C2 (ru) * | 2000-11-22 | 2002-11-20 | Нижегородское государственное предприятие по производству бактерийных препаратов - ИмБио | Способ получения биологически активного комплекса из животного сырья для терапевтического использования |
| RU2195296C2 (ru) * | 2000-04-12 | 2002-12-27 | Ставропольский научно-исследовательский противочумный институт | Способ получения ганглиозидов |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59222424A (ja) * | 1983-06-01 | 1984-12-14 | Katsutaka Nagai | 神経障害疾患治療剤 |
| IT1177863B (it) * | 1984-07-03 | 1987-08-26 | Fidia Farmaceutici | Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche |
| US5073543A (en) * | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1232176B (it) | 1989-07-27 | 1992-01-25 | Fidia Farmaceutici | Derivati di-lisogangliosidi |
| IT1238346B (it) * | 1989-11-14 | 1993-07-13 | Gangliosidi modificati e loro derivati funzionali. | |
| JPH0580009A (ja) * | 1991-09-20 | 1993-03-30 | Kubota Corp | 炭酸濃度測定方法 |
| JPH0580010A (ja) * | 1991-09-25 | 1993-03-30 | Kubota Corp | 気体中の炭酸ガス濃度測定方法 |
| JP4005115B1 (ja) | 2007-02-08 | 2007-11-07 | 日本臓器製薬株式会社 | 疼痛疾患治療剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT127981B (de) * | 1929-06-07 | 1932-04-25 | Schering Kahlbaum Ag | Verfahren zur Herstellung eines die zentralen Tätigkeiten fördernden und regulierenden Reizstoffes. |
| CH193176A (de) * | 1936-12-08 | 1937-09-30 | Richter Arthur | Verfahren zur Gewinnung eines Wirkstoffes aus Säugetiergehirn. |
| US3436413A (en) * | 1965-12-21 | 1969-04-01 | Canada Packers Ltd | Process for the isolation of phosphatidyl serine |
-
1975
- 1975-08-13 IT IT26323/75A patent/IT1046051B/it active Protection Beyond IP Right Term
- 1975-09-24 ES ES441233A patent/ES441233A1/es not_active Expired
- 1975-11-05 DE DE19752549680 patent/DE2549680A1/de active Granted
- 1975-12-30 FR FR7540170A patent/FR2320760A1/fr active Granted
-
1976
- 1976-07-01 BE BE168566A patent/BE843695A/xx not_active IP Right Cessation
- 1976-08-13 JP JP51097402A patent/JPS5234912A/ja active Granted
- 1976-08-13 AT AT606976A patent/AT352296B/de not_active IP Right Cessation
-
1987
- 1987-01-05 JP JP62000347A patent/JPS62187412A/ja active Granted
Non-Patent Citations (2)
| Title |
|---|
| CHEMICAL ABSTRACTS, VOL.57, REF. 12858H 1962 ) * |
| CHEMICAL ABSTRACTS, VOL.78, REF. 81662C 1973 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1980001875A1 (fr) * | 1979-03-16 | 1980-09-18 | Merieux Inst | Nouveau medicament, notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
| EP0016702A1 (fr) * | 1979-03-16 | 1980-10-01 | Institut Merieux | Médicament, notamment pour le traitement du choléra, et compositions pharmaceutiques le contenant |
| FR2451194A1 (fr) * | 1979-03-16 | 1980-10-10 | Merieux Inst | Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant |
| EP0038511A3 (en) * | 1980-04-17 | 1982-08-18 | Rolf Dr. Schaefer | Wound healing compositions |
| WO1981003175A1 (en) * | 1980-05-09 | 1981-11-12 | H Leffler | Carbohydrate derivatives for inhibiting bacterial adherence |
| US4464360A (en) * | 1980-05-09 | 1984-08-07 | Hakon Leffler | Glycosphingalipids for inhibiting bacterial adherence |
| EP0126817A1 (en) * | 1983-05-27 | 1984-12-05 | Shanksville Corporation N.V. | Suppressing of graft rejection in organ transplantation |
| EP0332191A3 (en) * | 1988-03-10 | 1990-05-16 | Mect Corporation | Sialosyl glyceride and process for producing the same |
| EP0409473A3 (en) * | 1989-07-12 | 1992-04-29 | Carlos Mammarella | A process for obtaining the gangliosides from nervous tissue of mammalians and for the treatment of psychoorganic diseases with said material compositons |
| RU2195296C2 (ru) * | 2000-04-12 | 2002-12-27 | Ставропольский научно-исследовательский противочумный институт | Способ получения ганглиозидов |
| RU2192871C2 (ru) * | 2000-11-22 | 2002-11-20 | Нижегородское государственное предприятие по производству бактерийных препаратов - ИмБио | Способ получения биологически активного комплекса из животного сырья для терапевтического использования |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6250450B2 (enExample) | 1987-10-24 |
| ATA606976A (de) | 1979-02-15 |
| JPS5234912A (en) | 1977-03-17 |
| JPS6256134B2 (enExample) | 1987-11-24 |
| DE2549680A1 (de) | 1977-02-24 |
| BE843695A (fr) | 1976-11-03 |
| IT1046051B (it) | 1980-06-30 |
| AT352296B (de) | 1979-09-10 |
| JPS62187412A (ja) | 1987-08-15 |
| ES441233A1 (es) | 1977-03-16 |
| FR2320760B1 (enExample) | 1978-11-17 |
| DE2549680C2 (enExample) | 1988-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2320760A1 (fr) | Utilisation therapeutique nouvelle des gangliosides et procede pour leur extraction | |
| MX9702284A (es) | Aparato vibrador particularmente util para dialisis. | |
| KR950016715A (ko) | 당의형 약학적 투여 단위 | |
| DE60217324D1 (de) | Pharmaceutishe zusammensetzung für die hormonersatztherapie | |
| FR2523441B1 (fr) | Dispositif therapeutique osmotique pour la distribution de deux substances differentes | |
| DE3176800D1 (en) | Oligosaccharides having selective anticoagulation activity | |
| ES2137948T3 (es) | Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina. | |
| IL65501A (en) | 1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them | |
| IL87160A (en) | Process for producing medicinal active substances by means of a printing process | |
| JPS5626820A (en) | Immunosuppressing agent | |
| PT79466A (en) | A kit or device and method for administering gangliosides and derivatives thereof by inhalation and pharmaceutical compositions suitable therefor | |
| DE3369998D1 (en) | Plasma protein solution with a clotting activity, process for its preparation and its use in the treatment of disorders of the hemostatic system | |
| GB2105201B (en) | Medical device for localised therapy | |
| DE3369195D1 (en) | Display unit of speedometer for automobile | |
| KR910700069A (ko) | Gm-csf를 사용한 백혈구 기능장애의 치료 | |
| BE888332A (fr) | Composes inhibiteurs de la biosynthese du cholesterol, leur procede de preparatio et de biosynthese du cholesterol. leur procede de preparation et leur application therapeutique, | |
| GR3003790T3 (enExample) | ||
| JPS5324038A (en) | Process for separating monosaccharide from mixture containing monosaccharide and oligosaccharide | |
| BE842730A (fr) | Dispositif monte sur vehicule, pour le traitement des liquides residuaires ou uses | |
| JPS55113721A (en) | Immunity regulator | |
| NO962503L (no) | Anvendelse av penoksyfyllin ved behandling av multippel sklerose | |
| EP0109859A3 (en) | Process for purifying and separating vatimin b12 | |
| JPS51120417A (en) | Systems for distributing liquid and recovery of vapor | |
| Malawista | Discussion: Clinical Features (Part Two) | |
| US4725625A (en) | Pharmaceutical composition and method for treating cachexia in humans due to cancer |